The War on Julie Boonstra . . . and other Obamacare

New Post Public Reply Private Reply Replies (0) Message Board
SaltyMutt
The War on Julie Boonstra
. . . and other Obamacare cancer victims.

By Henry Payne
March 15, 2014 4:00 AM



Michigan is a crucial piece on the 2014 U.S. Senate chessboard, and Republicans have a good shot at gaining retiring Democrat Carl Levin’s open seat, given Democratic nominee Gary Peters’s unpopular House vote for the Affordable Care Act. Yet Peters has hope. The president’s unilateral delays in Obamacare mandates have eased planned layoffs by local governments and businesses. Moderate GOP governor Rick Snyder supports the ACA’s Medicaid expansion. And the state’s liberal news media have largely ignored the estimated 225,000-plus canceled individual policies and the job losses at medical-device maker Stryker.

But Julie Boonstra won’t be ignored. So she must be destroyed.

The Dexter, Mich., leukemia victim lost her coverage last fall and now stars in a devastating ad fingering Obamacare — and Peters — for her resulting distress. In an extraordinary media counterstrike, Boonstra, a schoolteacher, has come under assault from Democrats and their media allies decrying her as a liar and an ignoramus for failing to embrace her new, Obamacare-approved plan.

As with outspoken female Obamacare cancer victims in other states, the intent is to intimidate critics from coming forward. Senator Harry Reid’s outrageous Senate-floor claim that all Obamacare horror stories “are untrue” is the mantra of the Democrats’ scorched-earth campaign to elect Peters and preserve a Democratic Senate.

Boonstra’s ad, backed by Americans for Prosperity , says her policy was “canceled because of Obamacare” and that she fears her “out-of-pocket costs are so high they are unaffordable.” Health-care experts like the Manhattan Institute’s Yevgeniy Feyman say Boonstra “has legitimate concerns.”

“It comes down to uncertainty,” Feyman says. “Cancer treatment is a very personal decision. Her new treatment may not take into account out-of-pocket costs. If her drugs are off the formulary, then [an ACA-mandated cost cap on out-of-pocket drug costs] doesn’t apply.”

“If I do not receive my medication, I will die,” worries Boonstra, who was invited to the State of the Union address as the guest of Representative Tim Walberg (R., Mich.). “I believed the president when he said I could keep my health- insurance plan . I feel lied to. Congressman Peters, your decision to vote for Obamacare jeopardized my health.”

Peters and the media have come out swinging, claiming Boonstra is a right-wing Koch-brothers tool (the Kochs donate to AFP). Like their fellow Democrats in office, newsrooms have long been sympathetic to universal health care.

“No doubt that was a difficult experience,” patronized Washington Post fact-checker Glenn Kessler before knocking Boonstra’s lack of enthusiasm for a lower-premium, higher-out-of-pocket-cost Blue Cross plan that Democrats insist is more affordable.

Michigan’s media piled on. The Detroit Free Press trumpeted Kessler’s claim that Boonstra was a liar deserving “two Pinocchios.” “A Dexter woman’s claims in a political ad criticizing U.S. Rep. Gary Peters don’t add up,” echoed MLive.com (a consortium of Booth newspapers in the state), faulting Boonstra’s math skills.

These organizations have ignored the details of Boonstra’s plan — instead using numbers from Blue Cross (an advocate for Obamacare) numbers to attack her. Through AFP spokesman Scott Hagerstrom, Boonstra communicated her concerns with her new plan.

Uncertainty dogs her — especially having been lied to once by the president. Where her canceled plan’s premiums once covered all her costs, she now must plan for out-of-pocket expenses. Those expenses are capped but will double to $10,200 if she goes out of her network — a not-uncommon need for cancer patients, whose treatment often changes — for a doctor or tests. Of her five cancer drugs, she has already discovered that one (Loratadine) is not covered. Detroit News columnist Dan Calabrese also unearthed the fact that glaucoma and “long-term care and nursing care are not covered.”

“She has been bedridden, had to sell her house, give up her teaching career,” says Hagerstrom. “She liked her insurance and now has to relive the uncertainty of five years ago.”

Rather than meeting with his constituent to hear her concerns, Peters tried to intimidate local news stations into pulling the ad, effectively silencing Boonstra. “Failure to prevent the airing of ‘false and misleading advertising’ can be cause for the loss of a station’s license,” wrote Peters through his legal counsel. Subtle as a club.

Peters’s threats received little Michigan media attention. Neither did Boonstra’s failed attempt to contact Peters. Michigan media ha internalized Reid’s mantra.

But Boonstra has not backed down. The leukemia victim wrote a letter this week to the Detroit News explaining the complexities of her situation.

“[My critics] choose to ignore the problems inherent with high out-of-pocket limits and prescriptions that aren’t covered for a person like me,” wrote Boonstra. “My new plan could mean wildly fluctuating and front-loaded costs in the first few months of the year. I chose my old plan — the one that Obamacare canceled — specifically so I could budget for the same monthly costs with certainty.”

The Boonstra attacks are not an isolated event. Cancer victim Edie Sundby was attacked by California Democrats and the Los Angeles Times when she wrote an op-ed critical of Obamacare in the Wall Street Journal. Democrats and their Spokane Review parrots thrashed Bette Grenier when she too dared question the ACA. And cancer victim Catherine Blackwood. And so on.

How many patients will be intimidated by such tactics? How many will persevere like Boonstra? It’s only March. Democrats are just getting warmed up.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Louisiana's Musical Legacy Gets a Boost from Foundation

Updated Category News Views 201

Preserving the Tunes of the Bayou Well, if that ain't music to your ears! The Louisiana First Horizon Foundation is sliding into the spotlight with news that's bound to strike a chord with any lover of the state's iconic rhythms. They're diving in deep, backing the Louisiana Music Museum right in the heart of Lafayette. Now, that ain't just another charity stunt; it's a...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 151

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
Future FinTech Under Investigation: Shareholder Impact Looms

Updated Category News Views 81

Future FinTech Faces Legal Scrutiny When the walls close in under financial suspicion, the spotlight can burn brighter than any anticipated market gain. That's precisely what Future FinTech Group Inc. (NasdaqCM: FTFT) is up against now. Kahn Swick & Foti, LLC, featuring the ex-Attorney General of Louisiana, Charles C. Foti, Jr., has begun scrutinizing the actions of...

Continue Reading
AXON Revenue Forecast Cut Spurs Legal Investigation

Updated Category News Views 135

Axon's Revenue Forecast Takes a Hit Listen up, folks. Axon Enterprise, Inc. (NASDAQ: AXON) has stirred the pot, cutting their 2026 revenue forecast faster than you can say "counter-drone deployment." Back in August, they were riding high on their second-quarter call, raising their growth forecast to a cheerful 32%-34%. Fast forward to November, and it's been slashed to...

Continue Reading
Cultural Bridges and Mazu's Spirit: Gen Z's Role

Updated Category News Views 138

Youthful Energy Revives Ancient Traditions Over in Putian, China, you'd have seen a curious sight in late October—hundreds of young folks from over 20 corners of the globe gathering not for a concert or some influencer meet-up, but to dive into Mazu's legacy. This ain't your typical cultural event. More than 200 Gen Z representatives came together, bridging their...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 73

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading
CleanSpark Sets Investor Events with Promising Outlook

Updated Category News Views 184

CleanSpark's Strategy Gets the Spotlight Looks like CleanSpark's stepping up to the plate, folks. They're shouting from the rooftops about hitting the upcoming investor events, and it’s no small potatoes. The company’s lined up a string of high-profile conferences, showcasing their ambition to stay ahead in the energy and data center games. We're talking about the...

Continue Reading
Century Lithium's 2026 AGM Time Clarification Issued

Updated Category News Views 129

Time Zone Confusion No More Ah, time zones. They just keep finding ways to trip up the folks at Century Lithium. The company’s got itself in a twist over when the Annual General Meeting's supposed to kick off. Turns out, they've clarified the timing for their 2026 AGM—it’s stamped for 10:00 a.m. Pacific Time. British Columbia’s ditched the seasonal time change, so...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 77

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
AZZ Inc.'s 2026 Sustainability Report: A Closer Look

Updated Category News Views 231

Diving into AZZ's Sustainability Commitment AZZ Inc., known in the trading circles as NYSE:AZZ, has just dropped its 2026 Sustainability Report and it’s quite the document to chew on. This ain't your typical corporate fluff. Tom Ferguson, the man steering the AZZ ship, laid it down plain and simple. This report isn’t just about ticking boxes for ESG; it’s reflecting...

Continue Reading

Top 5 Most Recently Viewed Articles

ImmunityBio Advances Towards EU Approval for Cancer Treatment

Updated Category News Views 95

ImmunityBio's Journey Towards EU Approval The European Medicines Agency (EMA) has made a significant recommendation toward approving ImmunityBio, Inc.’s Anktiva (nogapendekin alfa inbakicept), intended for use alongside Bacillus Calmette-Guérin (BCG) for treating BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). Clinical Trial Results and Findings This...

Continue Reading
Temperature Monitoring Systems Set to Reach $5.66 Billion by 2030

Updated Category News Views 139

Temperature Monitoring Systems Market Analysis and Growth Projections The temperature monitoring systems market, valued at USD 3.80 billion recently, is on a promising trajectory. It is expected to expand at a compound annual growth rate (CAGR) of 5.3%, reaching an impressive USD 5.66 billion by 2030. This growth can be attributed to several factors, including...

Continue Reading
Comparative Insights on Apple and Its Competitors' Performance

Updated Category News Views 336

Performance Insights into Apple and Industry Competitors In the ever-evolving realm of technology, understanding the dynamics of company performance is vital for investors and analysts. This analysis focuses on Apple Inc. (NASDAQ: AAPL) and its key competitors in the Technology Hardware, Storage & Peripherals sector. We'll delve into essential financial metrics, market...

Continue Reading
X Financial Achieves Impressive Growth in Recent Earnings

Updated Category News Views 108

X Financial Reveals Strong Q2 Performance X Financial (NYSE: XYF), a prominent player in the fintech industry, has reported robust financial results that highlight its significant growth and commitment to enhancing its service offering. The company recently disclosed its unaudited financial results for the second quarter, and the figures are quite remarkable. Q2 2025...

Continue Reading
Tyra Biosciences to Engage Investors at Major Conferences

Updated Category News Views 290

Tyra Biosciences to Engage Investors at Major Conferences Tyra Biosciences, Inc. (Nasdaq: TYRA) is a pioneering biotechnology company dedicated to crafting next-generation precision medicines with a keen focus on Fibroblast Growth Factor Receptor (FGFR) biology. The company has great momentum as it takes strides in engaging with investors at a series of crucial investor...

Continue Reading